Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma, Kaposi 2HIV Infections 2Acquired Immunodeficiency Syndrome 2

Interventions

Doxorubicin 18Vincristine 15Zidovudine 11Bleomycin 11Cyclophosphamide 9Etoposide 8Interferon alpha-2 6Prednisone 5Cytarabine 5tecogalan 4sargramostim 4Rituximab 4Polymerase Chain Reaction 4Liposomes 4Filgrastim 4Dexamethasone 4Methotrexate 3Leucovorin 3Fluorouracil 3interferon alfa-n1 2Watchful Waiting 2Vinblastine 2Tumor Necrosis Factor-alpha 2Thalidomide 2Semaxinib 2Ritonavir 2Peripheral Blood Stem Cell Transplantation 2Mitoxantrone 2Light Coagulation 2Isotretinoin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × HIV Infections × Didanosine × Clear all
NCT00001114 2021-11-01

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
90 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00000954 2021-10-29

A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
72 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡